Abstract
Congenital anomalies of the kidneys or lower urinary tract (CAKUT) are the most common causes of renal failure in children and lead to approximately 25% of end-stage renal disease in adults. Amongst the spectrum of anomalies includes renal duplication, cystic renal dysplasia, and Multicystic Dyplastic Kidney (MCDK). Developmental defects leading to these entities can occur in isolation or as part of a syndromic pattern. This chapter provides a practical overview of the diagnosis, pathophysiology, and management options for the common and most clinically significant congenital upper tract anomalies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Little MH, McMahon AP. Mammalian kidney development: principles, progress, and projections. Cold Spring Harb Perspect Biol. 2012;4:a008300.
Meyer R. Normal and abnormal development of the ureter in the human embryo; a mechanistic consideration. Anat Rec. 1946;96(4):355–71.
Whitten SM, Wilcox DT. Duplex systems. Prenat Diagn. 2001;21:952–7.
Bisset GS III, Strife JL. The duplex collecting system in girls with urinary tract infection: prevalence and significance. AJR Am J Roentgenol. 1987;148(3):497–500.
Afshar K, Papanikolaou F, Malek R, Bagli D, Pippi-Salle JL, Khoury A. Vesicoureteral reflux and complete ureteral duplication. Conservative or surgical management? J Urol. 2005;173(5):1725–7.
Belman AB, Filmer RB, King LR. Surgical management of duplication of the collecting system. J Urol. 1974;112(3):316–21.
Hensle TW, Reiley EA, Ritch C, Murphy A. The clinical utility and safety of the endoscopic treatment of vesicoureteral reflux in patients with duplex ureters. J Pediatr Urol. 2010;6(1):15–22.
Cain MP, Pope JC, Casale AJ, Adams MC, Keating MA, Rink RC. Natural history of refluxing distal ureteral stumps after nephrectomy and partial ureterectomy for vesicoureteral reflux. J Urol. 1998;160(3 Pt 2):1026–7.
De Caluwe D, Chertin B, Puri P. Fate of the retained ureteral stump after upper pole heminephrectomy in duplex kidneys. J Urol. 2002;168(2):679–80.
Caldamone AA, Snyder HM III, Duckett JW. Ureteroceles in children: followup of management with upper tract approach. J Urol. 1984;131(6):1130–2.
Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis. 1994;23(5):661–9.
Resseguie LJ, Nobrega FT, Farrow GM, Timmons JW, Worobec TG. Epidemiology of renal and ureteral cancer in Rochester, Minnesota, 1950-1974, with special reference to clinical and pathologic features. Mayo Clin Proc. 1978;53(8):503–10.
Truong LD, Choi YJ, Shen SS, Ayala G, Amato R, Krishnan B. Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol. 2003;10(3):135–59. Review
Heinz-Peer G, Schoder M, Rand T, Mayer G, Mostbeck GH. Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study. Radiology. 1995;195(3):667–71.
Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 2001;59(5):1654–62.
Liapis H, Winyard PJD. Cystic diseases and developmental kidney defects. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney, vol. 2. 6th ed. Philadephia: Lippincott Williams and Wilkins; 2007. p. 1257–306.
Harris PC, Rossetti S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010;6(4):197–206.
Wilson PD. Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell Biol. 2004;36(10):1868–73.
Keith DS, Torres VE, King BF, Zincki H, Farrow GM. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;4(9):1661–9. Review
Zerres K, Rudnik-Schöneborn S, Steinkamm C, Becker J, Mücher G. Autosomal recessive polycystic kidney disease. J Mol Med (Berl). 1998;76(5):303–9. Review
Winyard P, Chitty LS. Dysplastic kidneys. Semin Fetal Neonatal Med. 2008;13(3):142–51.
Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics. 2003;111(5 Pt 1):1072–80.
Bergmann C, Senderek J, Windelen E, Kupper F, Middeldorf I, Schneider F, Dornia C, Rudnik-Schoneborn S, Konrad M, Schmitt CP, Seeman T, Neuhaus TJ, Vester U, Kirfel J, Buttner R, Zerres K. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int. 2005;67(3):829–48.
Wang S, Zhang J, Nauli SM, Li X, Starremans PG, Luo Y, Roberts KA, Zhou J. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol Cell Biol. 2007;27(8):3241–52.
Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat-Kievit A, Zonnenberg B, Verhoef S, Halley D, van den Ouweland A. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet. 2005;13(6):731–41.
Chonko AM, Weiss SM, Stein JH, Ferris TF. Renal involvement in tuberous sclerosis. Am J Med. 1974;56(1):124–32.
Bernstein J. Renal cystic disease in the tuberous sclerosis complex. Pediatr Nephrol. 1993;7(4):490–5. Review
Neumann HP, Bender BU, Schultze-Seemann W, Krause T, Altehoefer C, Scheremet R, Orszagh M, Schwarzkopf G, Januszewicz A, Janetschek G, Riegler P. The kidney and von Hippel–Lindau disease: impact of molecular genetic analysis of the VHL gene for clinical management. Contrib Nephrol. 1997;122:102–8. Review
Levine E, Collins DL, Horton WA, Schimke RN. CT screening of the abdomen in von Hippel-Lindau disease. AJR Am J Roentgenol. 1982;139(3):505–10.
Tanagho EA. Surgically induced partial urinary obstruction in the fetal lamb. 3. Ureteral obstruction. Investig Urol. 1972;10(1):35–52.
Mackie GG, Stephens FD. Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice. J Urol. 1975;114(2):274–80.
al-Khaldi N, Watson AR, Zuccollo J, Twining P, Rose DH. Outcome of antenatally detected cystic dysplastic kidney disease. Arch Dis Child. 1994;70(6):520–2.
Flack CE, Bellinger MF. The multicystic dysplastic kidney and contralateral vesicoureteral reflux: protection of the solitary kidney. J Urol. 1993;150(6):1873–4.
Calaway AC, Whittam B, Szymanski DM, Misseri R, Kaefer M, Rink RC, et al. Multicystic dysplastic kidney: is an initial voiding cystourethrogram necessary? Can J Urol. 2014;21:7510–4.
Beckwith JB. Wilms tumor and multicystic dysplastic kidney disease. Editorial Comment J Urol. 1997;158:2259–60.
Noe HN, Marshall JH, Edwards OP. Nodular renal blastema in the multicystic kidney. J Urol. 1989;142:486–8.
Aslam M, Watson AR, on behalf of the Trent & Anglia MCDK Study Group. Unilateral multicystic dysplastic kidney: long term outcomes. Arch Dis Child. 2006;91:820–3.
Snodgrass WT. Hypertension associated with multicystic dysplastic kidney in children. J Urol. 2000;164(2):472–3;discussion 473–4
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chalmers, D. (2021). Congenital Upper Tract Anomalies: Duplication, Cystic Renal Dysplasia, Multicystic Dysplastic Kidney. In: Godbole, P., Wilcox, D.T., Koyle, M.A. (eds) Practical Pediatric Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-54020-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-54020-3_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54019-7
Online ISBN: 978-3-030-54020-3
eBook Packages: MedicineMedicine (R0)